455900.Kq

The company exhibits a strong liquidity position, with a current ratio of 23.43, indicating a significant excess of current assets over current liabilities. The price-to-book ratio of 12.78 suggests that the market is valuing the company's equity at a premium relative to its book value. However, the company's negative operating income of -10,276,486,750 KRW and net income of -9,715,061,270 KRW indicate a substantial loss-making position.

Profitability metrics show a return on equity of -29.78% and a return on assets of -26.23%, both significantly below the industry norms for a profitable medical equipment and supplies company. The gross profit of 2,611,240,700 KRW is insufficient to cover the company's operating expenses, contributing to the negative operating income. The company's debt-to-equity ratio of 0.04 indicates a low level of leverage, which is generally favorable for financial stability.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of diversification may expose the company to higher operational and market risks if the primary segment or region experiences a downturn. The company's capital structure is supported by a high level of equity, with total equity of 32,626,209,750 KRW, and a relatively small amount of long-term debt of 1,219,888,450 KRW.

The company's growth trajectory is currently negative, with a significant decline in operating and net income. The operating cash flow of -7,219,333,060 KRW and free cash flow of -8,864,085,330 KRW indicate a cash outflow, which may constrain the company's ability to invest in growth opportunities. The capital expenditure of -980,468,060 KRW suggests that the company is not currently investing in new assets, which could impact its long-term growth potential.

The company's risk assessment indicates low liquidity and dilution risks, with no immediate filing-based liquidity or dilution flags detected. The low debt-to-equity ratio and high current ratio support the low liquidity risk assessment. The company's capital structure and financial performance suggest that dilution is not a near-term concern.

Recent events and filings do not indicate any significant changes in the company's financial or operational status. The company's financial snapshot and valuation metrics suggest a need for strategic adjustments to improve profitability and cash flow. The absence of disclosed recent events or filings implies a stable but currently unprofitable operational environment.